Emberton M - Search Results

1

Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer.

Stabile A, Orczyk C, Hosking-Jervis F, Giganti F, Arya M, Hindley RG, Dickinson L, Allen C, Punwani S, Jameson C, Freeman A, McCartan N, Montorsi F, Briganti A, Ahmed HU, Emberton M, Moore CM. Stabile A, et al. Among authors: emberton m. BJU Int. 2019 Sep;124(3):431-440. doi: 10.1111/bju.14710. Epub 2019 Mar 18. BJU Int. 2019. PMID: 30753756 Free article.

2

Bile duct injury following laparoscopic cholecystectomy.

Cheslyn-Curtis S, Emberton M, Ahmed H, Williamson RC, Habib NA. Cheslyn-Curtis S, et al. Among authors: emberton m. Br J Surg. 1992 Mar;79(3):231-2. doi: 10.1002/bjs.1800790314. Br J Surg. 1992. PMID: 1532527 No abstract available.

3

A rare tumour in the pelvis presenting with lower urinary symptoms: 'sclerosing epithelioid fibrosarcoma'.

Arya M, Garcia-Montes F, Patel HR, Emberton M, Mundy AR. Arya M, et al. Among authors: emberton m. Eur J Surg Oncol. 2001 Feb;27(1):121-2. doi: 10.1053/ejso.2000.1023. Eur J Surg Oncol. 2001. PMID: 11237504 No abstract available.

4

Changes in patient characteristics and outcomes for radical cystectomy in England.

Nuttall MC, van der Meulen J, McIntosh G, Gillatt D, Emberton M. Nuttall MC, et al. Among authors: emberton m. BJU Int. 2005 Mar;95(4):513-6. doi: 10.1111/j.1464-410X.2005.05329.x. BJU Int. 2005. PMID: 15705070

5

Prolonging survival in prostate cancer: chemotherapy will have an important role.

Parker C, Emberton M. Parker C, et al. Among authors: emberton m. BJU Int. 2005 Jul;96(1):2-3. doi: 10.1111/j.1464-410X.2005.05554.x. BJU Int. 2005. PMID: 15963108 No abstract available.

6

Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?

Moore CM, Hoh IM, Bown SG, Emberton M. Moore CM, et al. Among authors: emberton m. BJU Int. 2005 Oct;96(6):754-8. doi: 10.1111/j.1464-410X.2005.05709.x. BJU Int. 2005. PMID: 16153193 Review. No abstract available.

7

Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.

Moore CM, Nathan TR, Lees WR, Mosse CA, Freeman A, Emberton M, Bown SG. Moore CM, et al. Among authors: emberton m. Lasers Surg Med. 2006 Jun;38(5):356-63. doi: 10.1002/lsm.20275. Lasers Surg Med. 2006. PMID: 16392142 Clinical Trial.

8

Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice.

Elhilali M, Emberton M, Matzkin H, van Moorselaar RJ, Hartung R, Harving N, Alcaraz A, Vallancien G; ALF-ONE Study Group. Elhilali M, et al. Among authors: emberton m. BJU Int. 2006 Mar;97(3):513-9. doi: 10.1111/j.1464-410X.2005.05962.x. BJU Int. 2006. PMID: 16469018

9

How good is MRI at detecting and characterising cancer within the prostate?

Kirkham AP, Emberton M, Allen C. Kirkham AP, et al. Among authors: emberton m. Eur Urol. 2006 Dec;50(6):1163-74; discussion 1175. doi: 10.1016/j.eururo.2006.06.025. Epub 2006 Jun 30. Eur Urol. 2006. PMID: 16842903 Review.

10

The thermo-expandable metallic stent for managing benign prostatic hyperplasia: a systematic review.

Armitage JN, Rashidian A, Cathcart PJ, Emberton M, van der Meulen JH. Armitage JN, et al. Among authors: emberton m. BJU Int. 2006 Oct;98(4):806-10. doi: 10.1111/j.1464-410X.2006.06399.x. Epub 2006 Jul 28. BJU Int. 2006. PMID: 16879446 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

562 results

Search Page